Bruker Corp (BRKR)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$45.45

Buy

$45.62

arrow-up$0.875 (+1.96%)

Prices updated at 19 Dec 2025, 15:08 EST
| Prices minimum 15 mins delay
|
Prices in USD

Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.

Income statement

20232024
2,965m3,366m
1,513m1,650m
489m379m
16.5011.26
427m113m
676m439m
Sales, General and administrative729m894m
Interest expenses16m48m
Provision for income taxes118m91m
Operating expenses1,024m1,270m
Income before taxes544m207m
Net income available to common shareholders427m113m
2.920.76
Net interest income-5m-39m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)2.90.76
Free cash flow per share1.39631.0581
Book value/share8.327111.9134
Debt equity ratio0.896821.224287

Balance sheet

20232024
Current assets2,164m2,053m
Current liabilities1,202m1,281m
Total capital2,538m3,843m
Total debt1,380m2,245m
Total equity1,377m1,781m
Total non current liabilities--
Loans1,160m2,062m
Total assets4,250m5,807m
Total liabilities--
Cash and cash equivalents488m183m
Common stock145m152m

Cash flow

20232024
Cash at beginning of period649m492m
Cash dividends paid-29m-30m
243m136m
Investments (gains) losses-326m-1,757m
492m187m
Net income--
350m251m
-107m-115m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.